Literature DB >> 34010645

The histone H3K9M mutation synergizes with H3K14 ubiquitylation to selectively sequester histone H3K9 methyltransferase Clr4 at heterochromatin.

Chun-Min Shan1, Jin-Kwang Kim2, Jiyong Wang1, Kehan Bao1, Yadong Sun1, Huijie Chen3, Jia-Xing Yue4, Alessandro Stirpe5, Zhiguo Zhang6, Chao Lu7, Thomas Schalch5, Gianni Liti4, Peter L Nagy3, Liang Tong1, Feng Qiao2, Songtao Jia8.   

Abstract

Oncogenic histone lysine-to-methionine mutations block the methylation of their corresponding lysine residues on wild-type histones. One attractive model is that these mutations sequester histone methyltransferases, but genome-wide studies show that mutant histones and histone methyltransferases often do not colocalize. Using chromatin immunoprecipitation sequencing (ChIP-seq), here, we show that, in fission yeast, even though H3K9M-containing nucleosomes are broadly distributed across the genome, the histone H3K9 methyltransferase Clr4 is mainly sequestered at pericentric repeats. This selective sequestration of Clr4 depends not only on H3K9M but also on H3K14 ubiquitylation (H3K14ub), a modification deposited by a Clr4-associated E3 ubiquitin ligase complex. In vitro, H3K14ub synergizes with H3K9M to interact with Clr4 and potentiates the inhibitory effects of H3K9M on Clr4 enzymatic activity. Moreover, binding kinetics show that H3K14ub overcomes the Clr4 aversion to H3K9M and reduces its dissociation. The selective sequestration model reconciles previous discrepancies and demonstrates the importance of protein-interaction kinetics in regulating biological processes.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34010645      PMCID: PMC8167812          DOI: 10.1016/j.celrep.2021.109137

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


INTRODUCTION

Recent sequencing analyses have found that histone lysine-to-methionine mutations are associated with distinct types of cancers. For example, more than 80% of diffuse intrinsic pontine gliomas contain a somatic K27M mutation in histone H3.3 or H3 (Schwartzentruber et al., 2012; Sturm et al., 2012; Wu et al., 2012), and more than 90% of chondroblastomas and a subset of head and neck squamous cell carcinomas contain a K36M mutation in histone H3.3 or H3 (Behjati et al., 2013; Papillon-Cavanagh et al., 2017). These mutations transform normal cells into tumor-like states, suggesting that they have critical roles in tumorigenesis (Chan et al., 2013a; Fang et al., 2016; Funato et al., 2014; Lu et al., 2016; Mohammad et al., 2017). Introducing histones containing lysine-to-methionine mutations, such as H3K9M, H3K27M, and H3K36M, into mammalian or yeast cells all reduced methylation of their corresponding lysine residues on wild-type histones (Brumbaugh et al., 2019; Chan et al., 2013a, 2013b; Fang et al., 2016; Herz et al., 2014; Lewis et al., 2013; Lu et al., 2016; Mohammad et al., 2017; Piunti et al., 2017; Sarthy et al., 2020; Shan et al., 2016; Stafford et al., 2018; Zhang et al., 2017), suggesting that they function in a dominant fashion and, possibly, through similar mechanisms. One of the most attractive models through which these mutations regulate global histone methylation is the sequestration of histone methyltransferases. Such a hypothesis is supported by interaction assays showing that K-to-M mutations enhanced the binding between histones and their methyltransferases both in vitro and in vivo (Bender et al., 2013; Chan et al., 2013a; Fang et al., 2016; Jayaram et al., 2016; Justin et al., 2016; Lu et al., 2016; Shan et al., 2016; Zhang et al., 2017). However, recent studies of the H3.3K27M mutation in vivo are not entirely consistent with the sequestration model. For example, chromatin immunoprecipitation sequencing (ChIP-seq) analyses of cancer cells expressing H3.3K27M found that, although the H3K27 methyltransferase PRC2 levels are higher at a set of poised enhancers that also contains H3.3K27M, most genomic loci containing high levels of H3.3K27M show no association with PRC2 (Fang et al., 2018; Piunti et al., 2017; Sarthy et al., 2020). Moreover, mass spectrometry analyses of proteins associated with H3.3K27M-containing nucleosomes did not detect higher levels of PRC2 than wild-type nucleosomes did (Herz et al., 2014). It is, therefore, critical to resolve these discrepancies to better understand the function of these mutations in tumorigenesis. We have previously established a model of the H3K9M mutation in fission yeast (Shan et al., 2016). In this organism, histone H3K9 methylation is required for the formation of heterochromatin at repetitive DNA elements (Grewal and Jia, 2007), and there are three copies of the histone H3 genes (hht1+, hht2+, and hht3+) with identical protein sequences. We have generated FLAG-tagged versions of wild-type and K9M mutant at the endogenous hht3+ locus. Western blot analysis with a histone H3 antibody indicates that the mutant histone is expressed at lower levels than endogenous histone H3 is (Figure 1A). We found that H3K9M dominantly blocks H3K9 methylation at major heterochromatin domains (Shan et al., 2016). Moreover, the H3K9M mutation enhances the interaction between the H3K9 methyltransferase Clr4 and histone H3 tail peptide in vitro, and that mutation results in higher levels of Clr4 at heterochromatin in vivo, leading to a model of H3K9M sequestering Clr4 to block H3K9 methylation (Shan et al., 2016).
Figure 1.

The selective sequestration of Clr4 at pericentric repeats by H3K9M

(A) Western blot of fission yeast cell extract with a H3 antibody. A non-specific band serves as a loading control.

(B) ChIP-seq analyses of Hht3 and Clr4 levels across the fission yeast genome. H3K9me3 data are derived from Shan et al., 2016. Diagrams of the three chromosomes are shown on top, with key positions, such as centromeres and telomeres, labeled as red circles. The region surrounding centromere I is enlarged and shown on the right. The white box indicates CENP-A containing chromatin, and the red arrows indicate pericentric heterochromatin in which H3K9me3 and Clr4 are enriched.

(C) ChIP analyses of FLAG-Clr4 and Hht3-GFP levels at pericentric dh repeats and act1+. Data are presented as means ± SD of three technical replicates.

In this study, we used that fission yeast H3K9M model to further examine whether the H3K9M mutation functions through the sequestration of Clr4. We found that, even though the H3K9M mutant histone is broadly distributed across the genome, Clr4 is only sequestered at heterochromatin, suggesting that additional mechanisms at heterochromatin might facilitate the sequestration of Clr4 by H3K9M. Clr4 associates with an E3 ubiquitin ligase complex, composed of Cul4, Rik1, Raf1, and Raf2 (Hong et al., 2005; Horn et al., 2005; Jia et al., 2005), to form CLRC. CLRC ubiquitylates histone H3K14 (H3K14ub), and H3K14ub is associated with H3K9me3 containing heterochromatin, but not H3K4me3 containing euchromatin (Oya et al., 2019; Stirpe et al., 2020). We found that mutating either CLRC or H3K14 abolished the sequestration of Clr4 by H3K9M. Furthermore, we show that in vitro, H3K9M works synergistically with H3K14ub to interact with Clr4, and H3K14ub potentiates the inhibitory effects of H3K9M. These results demonstrate that H3K14ub is critical for the sequestration of Clr4 by H3K9M.

RESULTS AND DISCUSSION

To further examine the mechanism by which H3K9M functions, we performed ChIP-seq analyses of Hht3-K9M and Clr4 (Figure 1B). In wild-type cells, Hht3 is broadly distributed across the genome, with the only exception being at the centromeric regions, in which histone H3 is replaced with a histone-variant CENP-A. Clr4 is mainly localized at pericentric regions, where many repetitive elements are present and H3K9me3 levels are high (Figure 1A). The localization pattern of Hht3-K9M is similar to that of wild-type Hht3 (Figure 1A), indicating that the mutation has little effect on the incorporation of histone H3 into chromatin. In hht3-K9M cells, Clr4 is still mainly enriched at pericentric repeats but with higher levels than found in wild-type cells (Figure 1B). ChIP-qPCR analyses of Clr4 and H3, using a strain expressing FLAG-Clr4 and Hht3-GFP, confirm that Clr4 levels increase at pericentric dh repeats, but not at euchromatic act1 locus in hht3-K9M cells (Figure 1C). Apparently, the broad distribution of Hht3-K9M does not result in the redistribution of Clr4 across the genome, suggesting that the intrinsic affinity between Clr4 and H3K9M alone is insufficient to sequester Clr4 on chromatin, but additional mechanisms promote the sequestration of Clr4 at pericentric repeats by H3K9M. The recent identification of CLRC as an E3 ubiquitin ligase of H3K14ub and the association of H3K14ub with heterochromatin (Oya et al., 2019; Stirpe et al., 2020) prompted us to check whether H3K14ub promotes the sequestration of Clr4 by H3K9M (Figure 2A). Interestingly, ChIP analyses show that Clr4 sequestration at pericentric repeats is abolished in rik1Δ hht3-K9M, raf1Δ hht3-K9M, and raf2Δ hht3-K9M cells (Figure 2B), suggesting that CLRC-mediated H3K14 ubiquitylation might indeed contribute to the sequestration of Clr4 at pericentric repeats. The complete loss of Clr4 at pericentric repeats is due to the fact that CLRC is critical for H3K9me3 and that H3K9me3 reinforces the localization of Clr4 through the interaction of H3K9me3 with the chromodomain of Clr4 (Zhang et al., 2008).
Figure 2.

The requirement of CLRC-mediated H3K14ub for the sequestration of Clr4 by H3K9M at heterochromatin in vivo

(A) Schematic diagram of CLRC in regulating H3K14ub and H3K9 methylation.

(B and D) ChIP analysis of FLAG-Clr4 levels at pericentric dh repeats, normalized to act1+. Data are presented as means ± SD of three technical replicates.

(C) Western blot analysis of Hht3 and Clr4 levels. Tubulin is used as loading control.

(E) Top, schematic diagram of the otr::ura4+ reporter. Bottom, serial dilution analysis of indicated strains to measure the expression of otr::ura4+.

(F) ChIP analysis of H3K9me3 levels at pericentric dh repeats, normalized to act1+. Data are presented as means ± SD of three technical replicates.

(G) qRT-PCR analysis of pericentric dh repeats, normalized to act1+. Data are presented as mean ± SD of 3 technical replicates.

(H) ChIP-seq analyses of H3K9me3 levels across the fission yeast genome in cells expressing H3K9MK14R.

See also Figure S1.

CLRC is targeted to repetitive DNA elements through the RNA interference (RNAi) pathway (Grewal and Jia, 2007) (Figure S1A). ChIP analyses show that Clr4 is not sequestered at pericentric repeats in hht3-K9M dcr1Δ, hht3-K9M ago1Δ, and hht3-K9M chp1Δ cells (Figure S1B). In contrast, the sequestration of Clr4 by H3K9M is independent of Swi6 (Figure S1B), which is an HP1 family protein essential for heterochromatin integrity but which functions downstream of CLRC. To further test the requirement for H3K14ub in the sequestration of Clr4 by H3K9M, we generated an hht3-K9MK14R mutation, which abolishes K14 ubiquitylation selectively on H3-containing K9M. Western blot analyses show that Hht3-K9MK14R and Hht3-K9M are expressed at similar levels (Figure 2C). ChIP analyses show that Clr4 levels at pericentric dh repeats in hht3-K9MK14R cells are reduced to wild-type levels (Figure 2D). We, then, further examined the effects of H3K9MK14R on heterochromatin function. Cells containing hht3-K9M are defective in the silencing of an otr::ura4+ reporter gene inserted at the pericentric repeats, leading to the robust growth of cells on medium without uracil and little growth on medium containing 5-FOA (fluoroorotic acid) (Figure 2E). These cells also lost H3K9me3 at pericentric dh repeats, accompanied by the accumulation of dh RNA transcripts (Figures 2F and 2G). In hht3-K9MK14R cells, the silencing of otr::ura4+ is similar to that in wild-type cells (Figure 2E). Moreover, H3K9me3 levels at pericentric dh repeats and dh RNA levels in hht3-K9MK14R cells are similar to those in wild-type cells (Figures 2F and 2G). Furthermore, ChIP-seq analysis shows that H3K9me3 levels are restored at all major heterochromatin domains in hht3-K9MK14R cells (Figure 2H). In contrast, hht1-K14R hht3-K9M cells are still defective in the silencing of otr::ura4+, consistent with the fact that H3K14ub function in cis to regulate the activity of Clr4 on H3K9 (Oya et al., 2019; Stirpe et al., 2020) (Figures S1C and S1D). To examine the effects of H3K14ub on the interaction between H3K9M and Clr4, we generated histone tail peptides containing ubiquitin mimics at H3K14. We synthesized biotin-tagged histone H3 tail peptides containing H3K14C and generated recombinant Ub-G76C. We then crosslinked the cysteines with 1,3 dichloroacetone (DCA) (Long et al., 2014) and purified the resulting peptides containing ubiquitin mimics at H3K14 to homogeneity (Figures 3A and S2). Peptide pull-down assays with recombinant Clr4 SET domain (residue 190–490) show that H3K9MK14ub interacts more strongly with Clr4 compared with H3K14C, H3K9MK14C, or H3K14ub in the presence of S-adenosyl-methionine (SAM) (Figure 3B). In addition, thermal shift assays also show that H3K9MK14ub interacts with Clr4 in the presence of SAM (Figure S3A), and Clr4 and H3K9MK14ub form a complex in the presence of SAM in a gel-filtration assay (Figures S3G and S3H). In the absence of SAM, H3K9MK14ub also results in a thermal shift of Clr4, although the shift is smaller than that observed in the presence of SAM (Figure S3B). In addition, H3K14ub results in an intermediate thermal shift of Clr4 in the absence of SAM, which is not observed in the presence of SAM. This is likely because the combination of Clr4, H3K14ub, and SAM results in H3K9 methylation reaction, which might lead to the dissociation of the complex. We also noticed that the addition of SAM alone, without peptide, results in greater thermal stability of Clr4, which might explain why SAM is important for binding (Figure S3C).
Figure 3.

H3K14ub enhances the interaction between Clr4 and H3K9M

(A) SDS-PAGE analysis of peptides used. The gel is stained with Coomassie blue.

(B) SDS-PAGE analysis of Clr4-SET bound to different peptides as well as the corresponding flow-through fractions. The gel is stained with Coomassie blue.

(C) BLI analyses of the interaction of Clr4-SET with different histone H3-tail peptides.

(D) ChIP analysis of FLAG-TetR-Clr4-SET levels at tetO at different time points after the addition of tetracycline, normalized to act1+. Data are presented as means ± SD of three technical replicates.

(E) In vitro histone methyltransferase assays using Clr4-SET, 3H-SAM, H3-tail peptide, and the indicated amounts of H3K9M or H3K9MK14ub peptides. The reaction product is resolved by SDS-PAGE, stained with Coomassie blue (bottom), and processed for fluorography (top).

(F) In vitro histone methyltransferase assays using Clr4-SET, SAM, H3-tail peptide, and varying amounts of H3K9M or H3K9MK14ub peptides. The concentration of methylation reaction product S-adenosyl-homocysteine (SAH) was measured by luminescence levels (RLUs, relative light units) after being processed with the MTase Glo assay kit. Data are presented as means ± SD of two technical replicates.

See also Figures S2–S4.

We further used bio-layer interferometry (BLI) to quantify the interactions (Figure 3C). In the presence of SAM, the equilibrium dissociation constant (KD) of the Clr4-SET interaction with H3K9MK14C, H3K14ub, and H3K9MK14ub is 1.42 μM, 0.61 μM, and 0.34 μM, respectively, whereas the KD of the Clr4 interaction with H3K14C is below detection. Comparing H3K9MK14C with H3K9MK14ub, k increases from 50,770 M−1s−1 to 118,400 M−1s−1, whereas k decreases from 0.0723 s−1 to 0.0405 s−1, resulting in t1/2 changes from 9.6 to 17.1 s. These results suggest that the presence of H3K14ub increases the association but decreases the dissociation of Clr4 with H3K9M. Comparing H3K14ub and H3K9MK14ub, the association rate k decreases from 228,900 M−1s−1 to 118,400 M−1s−1, whereas the dissociate rate k decreases from 0.1410 s−1 to 0.0405 s−1, resulting in t1/2 changes from 4.9 to 17.1 s. These results suggest that, in the presence of H3K14ub, it is more difficult for Clr4 to get on to H3K9M than on to H3K9. Once Clr4 is bound to H3K9M, it is also more difficult for Clr4 to get off. In the absence of SAM, Clr4-SET interaction with H3K14ub is mildly reduced (KD increased from 0.61 μM to 1.02 μM), but the interaction between Clr4-SET and H3K9MK14ub is reduced more dramatically (KD increased from 0.34 μM to 2.44 μM) (Figure S4A). SAM mainly affects the k of Clr4-SET and H3K9MK14ub interaction (1189,400 M−1s−1 and 23,550 M−1s−1 in the presence and absence of SAM, respectively), suggesting that the presence of SAM helps Clr4 recognize the H3K9M mutation. To examine whether the presence of H3K9M slows down the turnover of Clr4 on chromatin in vivo, we used a strain in which Clr4 is targeted to 10 copies of the tetO binding sites through a TetR-Clr4 fusion protein (Figure 3D), which results in the formation of a large, ectopic heterochromatin domain. This ectopic heterochromatin also depends on every component of CLRC (Ragunathan et al., 2015). ChIP analyses show that the addition of tetracycline results in the quick release of Clr4 from chromatin, with most TetR-Clr4 released from the tetO sites within 5 min of tetracycline addition (Figure 3D). In hht3-K9M cells, we observed a delay in the release of TetR-Clr4 (Figure 3D), suggesting that the presence of H3K9M-containing nucleosomes, indeed, slows down the turnover of Clr4 on chromatin. In both hht3-K9M rik1Δ and hht3-K9MK14R cells, the release of TetR-Clr4 is similar to the rate in wild-type cells, suggesting that H3K14ub contributes to the slow turnover of Clr4 on chromatin in hht3-K9M cells (Figure 3D). We also examined whether the presence of H3K14ub enhances the inhibitory effects of H3K9M on Clr4 enzymatic activity in vitro. Using a histone methyltransferase assay with recombinant Clr4 SET domain (190–490), 3H-labeled SAM as the methyl donor, and histone H3 tail peptide as the substrate, we found that H3K9MK14ub is a more-potent inhibitor compared with H3K9M (Figure 3E). A non-radioactive methyltransferase assay that measures the production of S-adenosyl-homocysteine also confirmed that conclusion (Figure 3F). Hydrogen/deuterium exchange coupled to mass spectrometry analysis shows that the interaction between Clr4 and H3K14ub is mediated by a hydrophobic surface of Clr4 that includes residues F256, F310, and F427 (Stirpe et al., 2020) (Figure 4A). We generated a recombinant Clr4 SET domain containing the F256A, F310A, and F427A mutations (3FA). That mutation strongly reduced the interaction between Clr4 and H3K14ub and has little effect on the structure of Clr4 (Stirpe et al., 2020). Peptide pull-down assays, thermal-shift assays, and BLI, all demonstrate that the 3FA mutation strongly reduces the interaction between Clr4 and H3K9MK14ub, either in the presence or in the absence of SAM (Figures 4B, 4C, S3D–S3F, S4B, and S4C). In addition, in vitro histone methyltransferase assays show that the 3FA mutant is less sensitive to H3K9MK14ub compared with that of wild-type Clr4 (Figures 4D and 4E), suggesting that the interaction of Clr4 with H3K14ub is critical for the inhibitory effects of H3K9M. To test the effects of 3FA on the sequestration of Clr4 by H3K9M in vivo, we generated a strain expressing TetR-Clr4-3FA. ChIP analyses show that TetR-Clr4-3FA is quickly released from the tetO locus in both wild-type and hht3-K9M cells (Figure 4F), suggesting that Clr4-3FA is not sequestered by H3K9M. We also used a strain expressing Clr4-3FA at its endogenous chromosomal locus. In hht3-K9M cells, the sequestration of Clr4-3FA mutant at pericentric repeats is abolished compared with that of wild-type Clr4 (Figure 4G). Again, the complete loss of Clr4-3FA at pericentric repeats is likely due to the requirement of H3K9me3 for the stable association of Clr4 at those regions, given the effect of Clr4-3FA on H3K9me3 in vivo (Stirpe et al., 2020). These results demonstrate that reducing the interaction between Clr4 and H3K9MK14ub decreases the inhibitory effects of H3K9M on Clr4 enzymatic activity and compromises the ability of H3K9M to sequester Clr4 on chromatin.
Figure 4.

The 3FA mutation comprised the interaction between Clr4 and H3K9MK14ub and relieved the sequestration of Clr4 by H3K9M in vivo

(A) Structure representation of Clr4 based on PDB: 6BP4 (Iglesias et al., 2018). The three residues mutated in 3FA (F256, F310, and F427), SAM, and the H3 peptide are presented as stick models. The H3 peptide is modeled based on the Dim-5-H3 complex structure (PDB: 1PEG) (Zhang et al., 2003).

(B) SDS-PAGE analysis of Clr4 or Clr4-3FA bound to H3K9MK14ub as well as the corresponding flow-through fraction. The gel is stained with Coomassie blue.

(C) BLI analysis of the interaction of Clr4-3FA H3K9MK14ub peptide.

(D) In vitro histone methyltransferase assays were performed with Clr4-SET, 3H-SAM, H3 tail peptide, and indicated amounts of H3K9M or H3K9MK14ub peptides.

(E) In vitro histone methyltransferase assays were performed with Clr4-SET, SAM, H3 peptide, and varying amounts of H3K9MK14ub peptides. The production of SAH was measured by luminescence levels after being processed with MTase Glo assay kit. Data are presented as means ± SD of two technical replicates.

(F) ChIP analysis of FLAG-TetR-Clr4 levels at pericentric tetO, normalized to act1+. Data are presented as means ± SD of three technical replicates.

(G) ChIP analysis of FLAG-Clr4 levels at pericentric dh repeats, normalized to act1+. Data are presented as means ± SD of three technical replicates.

(H) A model for the selective sequestration of Clr4 by H3K9M at pericentric repeats.

See also Figures S3 and S4.

Altogether, our results suggest that the affinity between Clr4 and H3K9M is low, thus H3K9M by itself is insufficient to sequester Clr4 on chromatin. At heterochromatin regions, CLRC catalyzes the H3K14ub, which increases the affinity of Clr4 to the H3 tail and enhances its enzymatic activity. H3K9M synergizes with H3K14ub to interact with Clr4, leading to the selective sequestration of Clr4 at heterochromatin. In euchromatin regions, the absence of H3K14ub coupled with the lower k of Clr4 to H3K9M prevents Clr4 sequestration by H3K9M due to the reduced ability of Clr4 to load on to H3K9M-containing nucleosomes (Figure 4H). In addition, our BLI data also highlights the importance of protein-protein interaction kinetic properties, which can be masked by affinity measurements, in regulating biological processes. One of the key discrepancies regarding the methyltransferase sequestration model is in the case of H3.3K27M, in which most foci with high levels of H3.3K27M show little enrichment of the H3K27 methyltransferase PRC2 (Piunti et al., 2017). Although the reason for such a discrepancy is complex (Fang et al., 2018; Sarthy et al., 2020; Stafford et al., 2018), we speculate that additional mechanisms at defined genomic locations might change the kinetic properties of PRC2-H3.3K27M interactions, leading to sequestration of PRC2 at selective loci. Indeed, in H3.3K27M-expressing cells, PRC2 is sequestered at poised enhancers (Fang et al., 2018), and the H3.3K27M-PRC2 interactions can be modulated by the presence of H3K27me3 (Diehl et al., 2019; Stafford et al., 2018). In addition, although H3K27M enhances the interaction between PRC2 and the H3 tail peptide, it has a minor role in the interaction between PRC2 and the nucleosome (Wang et al., 2017), which is consistent with the idea that H3K27M alone is insufficient to sequester PRC2. Interestingly, structural analysis shows that the association of PRC2 with nucleosome is regulated by JARID2-AEBP2 and H2AK119ub (Kasinath et al., 2021). It would be interesting to examine whether H2AK119ub promotes the sequestration of PRC2 by H3K27M, similar to the effects of H3K14ub on the sequestration of Clr4 by H3K9M. Similar to CLRC in fission yeast, the Neurospora crassa H3K9 methyltransferase Dim-5 and mammalian H3K9 methyltransferase SUV39H1 also associate with CUL4-based E3 ubiquitin ligase complexes (Lewis et al., 2010; Yang et al., 2015). In both organisms, CUL4, its adaptor protein DDB1, and the associated DCAFs (DDB1 and CUL4-associated factors) are also required for H3K9 methylation (Higa et al., 2006; Lewis et al., 2010; Xu et al., 2010; Zhao et al., 2010). Although mammalian CUL4-DDB1 complex ubiquitylates histone H3 in vitro (Wang et al., 2006), it remains to be determined whether CUL4-DDB1 ubiquitylates H3K14. H3K14ub stimulates the activity of mammalian H3K9 methyltransferase SUV39H1 in vitro (Stirpe et al., 2020), suggesting that the cross-talk between H3K14ub and H3K9me3 might be conserved. H3K14ub is detected by mass spectrometry analysis of mammalian histones (Kim et al., 2011). Therefore, it would be interesting to further examine whether the crosstalk between H3K14ub and H3K9me is conserved in higher organisms in vivo and how H3K14ub is regulated during biological processes.

STAR★METHODS

RESOURCE AVAILABILITY

Lead contact

Further information and request for resources and reagents should be directed to and will be fulfilled by the Lead contact, Songtao Jia (songtao.jia@columbia.edu).

Materials availability

The materials generated in this study is available upon request and will be shared without restriction.

Data and code availability

The accession number for the RNA-seq, MNase-seq, and ChIP-seq data reported in this paper are GEO: GSE159192.

EXPERIMENTAL MODEL AND SUBJECT DETAILS

A list of yeast strains used is provided in Table S1. Yeast strains containing hht3-K9MK14R or hht1-K14R were generated by a PCR-based module method. All other strains were published or constructed through genetic crosses.

METHOD DETAILS

Serial dilution analyses

For serial dilution plating assays, ten-fold dilutions of a mid log-phase culture were plated on the indicated medium and grown for 3 days at 30°C.

Chromatin immunoprecipitation (ChIP) analyses

Log-phase yeast cells grown at 30°C were incubated at 18°C for 2 hours and then fixed for 30 minutes in 3% freshly made formaldehyde. The cells were pelleted and washed with PBS (phosphate-buffered saline) before resuspended in ChIP lysis buffer (50 mM HEPES-KOH, pH 7.5, 140 mM NaCl, 1% Triton X-100, 0.1% Deoxycholate). Ice cold glass beads were added and the mixtures were vigorously disrupted in a beadbeater. The lysates were collected and subjected to sonication to reduce chromatin size to 500–1000 base pairs (bp). The cleared cell lysates were incubated with Flag-agarose beads (Sigma) overnight at 4°C. The beads were then washed with ChIP lysis buffer twice, ChIP lysis buffer containing 0.5 M NaCl, Wash buffer (10 mM Tris, pH 8.0, 250 mM LiCl, 0.5% NP-40, 0.5% Deoxycholate, 1 mM EDTA), and TE (50 mM Tris pH 8.0, 1 mM EDTA). The bound chromatin fragments were eluted with TES (50 mM Tris pH 8.0, 1 mM EDTA, 1% SDS), and the crosslinking was reversed by incubating at 65°C overnight. The protein DNA mixture was then subjected to proteinase K treatment and phenol:chloroform extraction before the DNA was precipitated by ethanol. For TetR-Clr4 release, tetracycline was added to log-phase cultures at 30°C to a final concentration of 10 μM and samples were taken at 5, 10, and 20 minutes, fixed with 3% freshly made formaldehyde for 30 minutes at 18°C. Quantitative real-time PCR (qPCR) was performed with Maxima SYBR Green qPCR Master Mix (Fermentas) in a StepOne Plus Real-Time PCR System (Applied Biosystems). DNA serial dilutions were used as templates to generate a standard curve of amplification for each pair of primers, and the relative concentration of the target sequence was calculated accordingly. An act1 fragment was used as a reference to calculate the enrichment of ChIP over the whole-cell extract (WCE) for each target sequence. A list of DNA oligos used is provided in the Key resources table.

KEY RESOURCES TABLE

REAGENT or RESOURCESOURCEIDENTIFIER
Antibodies
Anti-flag M2 affinity gelSigmaCat# A2220; RRID:AB_10063035
Anti-TublinKeith Gull labN/A
Mouse Anti-Green Fluorescent Protein (GFP) Monoclonal AntibodyCovanceCat# MMS-118P-500; RRID:AB_291290
Mouse monoclonal anti-FLAGSigmaCat#F3165; RRID:AB_259529
Chemicals, peptides, and recombinant proteins
2,2′-Dithiobis(5-nitropyridine)(DCA)Sigma-AldrichCat#158194
5-Fluoroorotic Acid Monohydrate (FOA, 5-FOA)US BiologicalCat#F5050
D-biotinSigma-AldrichCat#2031
EN3HANCEPerkin ElmerCat#6NE9701
Formaldehyde, 37% solutionSigmaCat#F8775
H3K14C-biotin, H3K9MK14C-biotin peptidesBiomatikCustom
Hygromycin BGold BiotechnologyCat#H-270-10
Isopropyl-1-thio-D-galactopyranoside (IPTG)Fisher BioreagentsCat#BP1755
MNaseThermo Fisher ScientificCat#88216
Phenol-chloroform-isoamyl alcohol mixtureSigmaCat#77617
Proteinase KInvitrogenCat#10005393
RNAase AThermo Fisher ScientificCat#EN0531
S-Adenosyl methionine (SAM)SigmaCat#A7007
Sodium deoxycholateSigma-AldrichCat#D6750
SYPRO orangeInvitrogenCat#S6650
Tris (2-carboxyethyl) phosphine hydrochloride (TCEP)AldrichCat#C4706
3H-SAMPerkin ElmerCat#NET155H250UC
Critical commercial assays
Power SYBR Green RNA-to-CT one-step KitThermo Fisher Scientific4389986
MasterPure yeast RNA purification kitEpicenterMPY03100
Maxima SYBR Green qPCR Master MixThermoFisher ScientificK0223
Avidin agarose columnThermo Scientific20228
Talon metal affinity resinTakaraBio USA635501
MTase-Glo Methyltransferase Assay kitPromegaV7601
Deposited data
Sequencing DataThis paperGSE159192
Experimental models: Organisms/strains
S. pombe, see Table S1Jia Lab StrainsN/A
Oligonucleotides
Primer: qPCR at act1+, Forward: GGTGGTATGAAGCCGTTGATThis paperN/A
Primer: qPCR at act1+, Reverse: AGTGCTAACGCTGTGTGTGGThis paperN/A
Primer: qPCR at dh, Forward: AATGACAAAGGTGCCGAATCThis paperN/A
Primer: qPCR at dh, Reverse: CGTTGAATGTTGTTGCTTTCAThis paperN/A
Primer: qPCR at tetO, Forward: AATGACAAAGGTGCCGAATCThis paperN/A
Primer: qPCR at tetO, Reverse: CTTCCCTGCCTATCGACAACThis paperN/A
Software and algorithms
Picard tools v2.0.1Broad Institute, MIThttps://broadinstitute.github.io/picard/
Trimmomatic v0.35Max Planck Institute of Molecular Plant Physiologyhttp://www.usadellab.org/cms/?page=trimmomatic
ForteBio Data analysisForteBiov10.0.1.6
Samtools v1.2Wellcome Trust Sanger Institutehttp://samtools.sourceforge.net/
GATK v3.5Broad Institute, MIThttps://github.com/broadinstitute/gatk/releases
Bwa v0.7.12-r1039Wellcome Trust Sanger Institutehttp://bio-bwa.sourceforge.net
Bedtools v2.25.0University of Utahhttps://bedtools.readthedocs.io/en/latest/

ChIP-seq

DNA samples were prepared according to TruSeq ChIP sample preparation guide (Illumina) and sequenced on the Illumina HiSeq 2500 system by 100-bp paired-end sequencing. The raw reads were trimmed by Trimmomatic (v0.35) to remove remaining adaptor contaminants and low-quality regions. The trimmed reads were aligned to the S. pombe reference genome (Ensembl assembly version: ASM294v2.29) by bwa (v0.7.12-r1039) (http://bio-bwa.sourceforge.net/). The read-mapping files were further processed by Samtools (v1.2) picard-tools (v2.0.1) (http://broadinstitute.github.io/picard/) and GATK (v3.5) for indexing, sorting, PCR duplicates removal, and local-realignment around Indels. The per-based mapping depth was calculated by bedtools (v2.25.0) and the sliding window analyses were further performed using a 100-bp window size and 50-bp step size. ChIP-seq data is available at GEO: GSE159192.

ChIP-seq of H3K9me3 in hht3-K9MK14R cells

Log-phase yeast cells were crosslinked with 1% formaldehyde for 20 minutes with shaking at room temperature, followed by 5 minutes quenching with 125mM glycine. Cells were harvested, washed with PBS (phosphate-buffered saline) and flashfrozen with liquid nitrogen. The thawed pellet was washed and then resuspended in ChIP lysis buffer (50 mM HEPES-KOH, pH 7.5, 140 mM NaCl, 1% Triton X-100, 0.1% Deoxycholate, 1mM PMSF). Ice-cold glass beads were added and the mixtures were vigorously disrupted in a bead-beater with four 30 s rounds. The lysates were collected and NP buffer was added (10 mM Tris, pH 7.4, 1 M sorbitol, 50 mM NaCl, 5 mM MgCl2, 1 mM CaCl2). MNase was added to the reaction and the reactions were incubated at 37°C for 20 minutes. MNase amount was titrated empirically so that the chromatin was digested to yield mainly mono- and di-nucleosomes. The reaction was stopped by the addition of 0.5 M EDTA, and the tubes were placed on ice. 5X ChIP lysis buffer was added to the reaction, mixed by short vertexing, and the tubes were incubated on ice for 30 minutes. The reactions were then cleared by centrifugation at 16,000 × g for 10 minutes. A small fraction of the cleared supernatant was reserved as input and the rest was used for immunoprecipitation. The protocols for immunoprecipitation, reverse-crosslinking, and DNA precipitation are the same as in the previous ChIP section. The precipitated DNA was treated with RNAase A (EN0531, Thermo Fisher Scientific) for 1 hour at 37°C. DNA concentration was determined with the Qubit dsDNA HS Assay Kit (Q33230, Thermo Fisher Scientific). 1–5 ng of ChIP and input DNA were used for library construction using the NEBNext Ultra II DNA Library Prep Kit for Illumina (E7645, NEB). Libraries were pooled and sequenced with single-end sequencing on a NextSeq500/550 at the JP Sulzberger Genome Center at Columbia University. Sequencing reads were de-multiplexed and aligned to the S. pombe reference genome (ASM294v2), obtained from Pombase (Lock et al., 2019) with Bowtie2 using default parameters (Langmead and Salzberg, 2012). Genome-wide coverage was calculated with deepTools2 (Ramírez et al., 2016) and normalized to counts per million (CPM). The coverage plot was visualized with IGV (Robinson et al., 2011). ChIP-seq experiments were performed in duplicates for each genotype.

RNA analyses

Total cellular RNA was isolated from log-phase cells using MasterPure yeast RNA purification kit (Epicenter) according to the manufacturer’s protocol. qRT-PCR analyses were performed with Power SYBR® Green RNA-to-CT 1-Step Kit (Thermo Fisher Scientific) in a StepOne Plus Real-Time PCR System (Applied Biosystems). RNA serial dilutions were used as templates to generate a standard curve of amplification for each pair of primers, and the relative concentration of the target sequence was calculated accordingly. An act1 fragment served as a reference to normalize the concentration of samples. The concentration of each target gene in wild-type cells was arbitrarily set to 1 and served as a reference for other samples. A list of DNA oligos used is provided in STAR Methods.

Western blot analyses

Cell lysates were prepared by lysing yeast cells with a beadbeater in ChIP lysis buffer. The lysates were sonicated for a total of 10 minutes to fragment chromatin. The cleared lysates were mixed with 2xSDS loading dye and resolved by SDS-PAGE. Western blot analyses were performed with Flag (Sigma), GFP (Covance), and Tubulin antibodies.

Generation of peptides containing H3K14ub mimics

Histone H3 tail peptides with a C-terminal biotinylated lysine, H3K14C (residues 1–21, ARTKQTARKSTGGCAPRKQLAGGK-biotin) and H3K9MK14C (ARTKQTARMSTG GCAPRKQLAGGK-biotin) were synthesized by Biomatik. Recombinant 6xHis tagged Ub-G76C was purified from E.coli using Talon beads according to manufacturer’s protocol (Takara). Peptides and Ub-G76C were mixed in a buffer of 50 mM Borate pH 8.1, 2 mM TCEP to a final concentration of 200 μM peptide and 100 μM Ub. The mixture was incubated at 37°C for 30 minutes and cool on ice for additional 30 minutes. Freshly made DCA was added to a final concentration of 100 μM and the mixture was incubated on ice for 1 hour. The reaction is quenched by the addition of 5 mM mercaptoethanol. The reaction mixture was first purified with an ULTRA-15ml centrifugal filter (10KDa cutoff, Amicon) to remove unreacted peptides and self-ligated peptides, and then further purified with Avidin agarose column (Thermo Scientific). The column was washed with PBS first, and then blocked with Biotin Blocking/Elution Buffer (2 mM D-biotin in PBS). After washing with Regeneration buffer (0.1M glycine, pH 2.8) and PBS, samples were loaded onto the column, and the column was then washed with PBS. H3K14ub mimics were eluted with Regeneration buffer.

Protein expression and purification

The SET domain of recombinant Clr4 (residues 190–490) and the 3FA mutant were cloned into a pET28a vector. The expression plasmids were transformed into Rosetta cells and protein expression was induced using 0.15 mM isopropyl-1-thio-D-galactopyranoside. After incubation overnight at 16 C, the cells were harvested and resuspended in lysis buffer (50 mM sodium phosphate, 300 mM NaCl, pH 7.0), supplemented with 2 mM β-mercaptoethanol and lysed with ultrasonication. The lysate was incubated with Talon metal affinity resin (Takara Bio USA) and then washed with lysis buffer containing 15 mM imidazole. Bound protein was eluted with lysis buffer containing 150 mM imidazole.

Peptide binding assays

Protein binding assays were performed by incubating recombinant proteins with biotinylated histone peptides in binding buffer (10mM Tris, 150 mM NaCl, 1mM EDTA, 1mM DTT, 10 μM SAM, 0.05% NP-40) for one hour at 30°C. Streptavidin beads were added to isolate biotinylated peptide and associated proteins. The beads were washed four times in binding buffer. The proteins bound to the beads were resolved by SDS-PAGE and stained with Coomassie blue.

Thermal shift assay

The thermal stability of the SET domain of clr4 with ligands was analyzed at various temperatures using the Mx3005 P Real-Time PCR system (Stratagene). Purified Clr4-SET or Clr4-SET-3FA mutant (3 μM) protein was incubated with 20 μM of H3K14C peptide, H3K9MK14C, H3K14ub, or H3K9MK14ub, in the presences of 150 μM of SAM. All assays were performed in duplicate for each sample and contained final concentrations of 50 mM Tris (pH 8.0), 1 mM EDTA and 0.5 mM DTT. Reactions were first incubated at room temperature for 10 minutes, then on ice for 10 minutes, and mixed with the fluorescence dye (SYPRO orange; Invitrogen). The temperature was increased from 25 to 99 °C in 1 C intervals over a 75-min period. Fluorescence values for each curve were normalized to the maximum and the minimum of the curve.

Biolayer interferometry

BLI analyses were performed in black 96-well plates (greinerbio-one, Germany) on an OctetRED96 instrument (ForteBio, USA). Prior to use, biosensors were soaked in assay buffer (1X PBS, 0.01% NP-40, 0.5 mM DTT, and 0.2 ug/ml BSA) for 10 min. BLI assays consisted of six steps, all performed in the assay buffer: initial baseline (30 s), loading (120 s), and quenching (120 s), baseline (60 s), association (30 s), and dissociation (90 s). Each biotinylated peptide (3 μg/ml) was immobilized on the Streptavidin biosensor tip during the loading step. To quench free streptavidin, 4 μg/ml of biocytin (Sigma), a biotin analog, was used. During the association step, analyte (Clr4-SET WT or 3FA mutant) at various concentrations was diluted into the assay buffer. Biotinylated-peptide-loaded sensors itself was measured as a control to subtract from experimental values before data processing. Sensorgrams were fit using global/1:1 binding model by ForteBio Data analysis version 10.0.1.6, from which the equilibrium dissociation constant (Kd) and association (k) and dissociation (k) rate constants were calculated. To measure the interaction in the presence of SAM, the assay buffer in all steps was supplied with 10 μM SAM.

In vitro histone methyltransferase assays

Histone methyltransferase assays were performed with recombinant Clr4 SET domain (25 nM), histone H3 tail peptide (residue 1–21) (1 μM) in histone methyltransferase buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 1 mM DTT, 2 μM SAM) containing 3H-SAM (400 nM) for 30 minutes at 25°C. The samples were resolved by SDS-PAGE and subjected to Coomassie staining to visualize the proteins and then treated with EN3HANCE (Perkin Elmer) to visualize labeled substrates. For non-radioactive histone methyltransferase assays, recombinant Clr4 SET domain (50 nM) were incubated histone H3 tail peptide (residue 1–21) (10 μM) in histone methyltransferase buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 1 mM DTT, 10 μM SAM) for 60 minutes at 25°C. The production of SAH was measured by the MTase-Glo Methyltransferase Assay kit according to the manufacture’s protocol. Luminescence was measured using a Synergy Neo2 Microplate reader (BioTek Instruments).

QUANTIFICATION AND STATISTICAL ANALYSIS

For ChIP-qPCR, qRT-PCR, and HMTase assays, data are presented as mean ± SD with the number of technical replicates indicated.
  47 in total

1.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.

Authors:  Jeremy Schwartzentruber; Andrey Korshunov; Xiao-Yang Liu; David T W Jones; Elke Pfaff; Karine Jacob; Dominik Sturm; Adam M Fontebasso; Dong-Anh Khuong Quang; Martje Tönjes; Volker Hovestadt; Steffen Albrecht; Marcel Kool; Andre Nantel; Carolin Konermann; Anders Lindroth; Natalie Jäger; Tobias Rausch; Marina Ryzhova; Jan O Korbel; Thomas Hielscher; Peter Hauser; Miklos Garami; Almos Klekner; Laszlo Bognar; Martin Ebinger; Martin U Schuhmann; Wolfram Scheurlen; Arnulf Pekrun; Michael C Frühwald; Wolfgang Roggendorf; Christoph Kramm; Matthias Dürken; Jeffrey Atkinson; Pierre Lepage; Alexandre Montpetit; Magdalena Zakrzewska; Krzystof Zakrzewski; Pawel P Liberski; Zhifeng Dong; Peter Siegel; Andreas E Kulozik; Marc Zapatka; Abhijit Guha; David Malkin; Jörg Felsberg; Guido Reifenberger; Andreas von Deimling; Koichi Ichimura; V Peter Collins; Hendrik Witt; Till Milde; Olaf Witt; Cindy Zhang; Pedro Castelo-Branco; Peter Lichter; Damien Faury; Uri Tabori; Christoph Plass; Jacek Majewski; Stefan M Pfister; Nada Jabado
Journal:  Nature       Date:  2012-01-29       Impact factor: 49.962

2.  Ubiquitin ligase component Cul4 associates with Clr4 histone methyltransferase to assemble heterochromatin.

Authors:  Songtao Jia; Ryuji Kobayashi; Shiv I S Grewal
Journal:  Nat Cell Biol       Date:  2005-08-28       Impact factor: 28.824

3.  Generation of nonhydrolyzable ubiquitin-histone mimics.

Authors:  Lindsey Long; Melonnie Furgason; Tingting Yao
Journal:  Methods       Date:  2014-07-23       Impact factor: 3.608

4.  CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation.

Authors:  Leigh Ann Higa; Min Wu; Tao Ye; Ryuji Kobayashi; Hong Sun; Hui Zhang
Journal:  Nat Cell Biol       Date:  2006-10-15       Impact factor: 28.824

5.  CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing.

Authors:  Y Yang; R Liu; R Qiu; Y Zheng; W Huang; H Hu; Q Ji; H He; Y Shang; Y Gong; Y Wang
Journal:  Oncogene       Date:  2013-12-02       Impact factor: 9.867

6.  Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling.

Authors:  Hans-Martin Herz; Marc Morgan; Xin Gao; Jessica Jackson; Ryan Rickels; Selene K Swanson; Laurence Florens; Michael P Washburn; Joel C Eissenberg; Ali Shilatifard
Journal:  Science       Date:  2014-08-29       Impact factor: 47.728

7.  The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression.

Authors:  Kui-Ming Chan; Dong Fang; Haiyun Gan; Rintaro Hashizume; Chuanhe Yu; Mark Schroeder; Nalin Gupta; Sabine Mueller; C David James; Robert Jenkins; Jann Sarkaria; Zhiguo Zhang
Journal:  Genes Dev       Date:  2013-04-19       Impact factor: 11.361

8.  A histone H3K9M mutation traps histone methyltransferase Clr4 to prevent heterochromatin spreading.

Authors:  Chun-Min Shan; Jiyong Wang; Ke Xu; Huijie Chen; Jia-Xing Yue; Stuart Andrews; James J Moresco; John R Yates; Peter L Nagy; Liang Tong; Songtao Jia
Journal:  Elife       Date:  2016-09-20       Impact factor: 8.140

9.  PomBase 2018: user-driven reimplementation of the fission yeast database provides rapid and intuitive access to diverse, interconnected information.

Authors:  Antonia Lock; Kim Rutherford; Midori A Harris; Jacqueline Hayles; Stephen G Oliver; Jürg Bähler; Valerie Wood
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

10.  H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers.

Authors:  Dong Fang; Haiyun Gan; Liang Cheng; Jeong-Heon Lee; Hui Zhou; Jann N Sarkaria; David J Daniels; Zhiguo Zhang
Journal:  Elife       Date:  2018-06-22       Impact factor: 8.140

View more
  1 in total

Review 1.  Leaving histone unturned for epigenetic inheritance.

Authors:  Chun-Min Shan; Yimeng Fang; Songtao Jia
Journal:  FEBS J       Date:  2021-11-02       Impact factor: 5.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.